Lung neoplasm malignant and Blood magnesium decreased

Summary:

Blood magnesium decreased is found among people with Lung neoplasm malignant, especially for people who are female, 60+ old.

The study analyzes which people have Blood magnesium decreased with Lung neoplasm malignant. It is created by eHealthMe based on reports of 58 people who have Lung neoplasm malignant from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Lung neoplasm malignant?

Lung neoplasm malignant (cancer tumour of lung) is found to be associated with 1,150 drugs and 926 conditions by eHealthMe. Check the latest studies of Lung neoplasm malignant.

What is Blood magnesium decreased?

Blood magnesium decreased is found to be associated with 966 drugs and 895 conditions by eHealthMe. Check the latest studies of Blood magnesium decreased.



On Jul, 17, 2026

58 people who have Lung Neoplasm Malignant and Blood Magnesium Decreased are studied.

Would you have Blood magnesium decreased when you have Lung neoplasm malignant?

Gender of people who have Lung Neoplasm Malignant and experienced Blood Magnesium Decreased *:

  • female: 65.52 %
  • male: 34.48 %

Age of people who have Lung Neoplasm Malignant and experienced Blood Magnesium Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 13.95 %
  • 60+: 86.05 %

Common co-existing conditions for these people *:

  1. Lung Cancer - Non-Small Cell (lung cancer): 5 people, 8.62%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 6.90%
  3. Brain Stem Haemorrhage (bleeding into structures of brain stem): 3 people, 5.17%
  4. High Blood Pressure: 3 people, 5.17%
  5. Nausea (feeling of having an urge to vomit): 2 people, 3.45%
  6. Bleeding Disorders: 2 people, 3.45%
  7. Breast Cancer: 2 people, 3.45%
  8. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 3.45%
  9. High Blood Cholesterol: 2 people, 3.45%
  10. Metastases To Central Nervous System (cancer spreads to central nervous system): 2 people, 3.45%

Common drugs taken by these people *:

  1. Tarceva: 13 people, 22.41%
  2. Magnesium: 9 people, 15.52%
  3. Lisinopril: 9 people, 15.52%
  4. Pantoprazole: 8 people, 13.79%
  5. Protonix: 7 people, 12.07%
  6. Folic Acid: 7 people, 12.07%
  7. Gabapentin: 6 people, 10.34%
  8. Ondansetron: 6 people, 10.34%
  9. Aspirin: 6 people, 10.34%
  10. Vitamin D3: 5 people, 8.62%

Common symptoms for these people *:

  1. Diarrhea: 26 people, 44.83%
  2. Blood Potassium Decreased: 21 people, 36.21%
  3. Nausea (feeling of having an urge to vomit): 18 people, 31.03%
  4. Rashes (redness): 15 people, 25.86%
  5. Fatigue (feeling of tiredness): 12 people, 20.69%
  6. High Blood Pressure: 11 people, 18.97%
  7. Weight Decreased: 11 people, 18.97%
  8. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 13.79%
  9. Dehydration (dryness resulting from the removal of water): 8 people, 13.79%
  10. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 7 people, 12.07%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Blood magnesium decreased?

- Check whether Blood magnesium decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Blood magnesium decreased:

All the conditions that are associated with Blood magnesium decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Blood magnesium decreased and Lung neoplasm malignant, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: